Compass Wealth Management LLC Buys Shares of 11,499 SPDR S&P Biotech ETF $XBI

Compass Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 11,499 shares of the exchange traded fund’s stock, valued at approximately $1,167,000.

Other hedge funds have also recently bought and sold shares of the company. NewEdge Wealth LLC raised its holdings in SPDR S&P Biotech ETF by 5.7% during the third quarter. NewEdge Wealth LLC now owns 3,504 shares of the exchange traded fund’s stock worth $383,000 after purchasing an additional 188 shares during the last quarter. Essex Financial Services Inc. increased its position in shares of SPDR S&P Biotech ETF by 9.0% in the third quarter. Essex Financial Services Inc. now owns 4,502 shares of the exchange traded fund’s stock valued at $451,000 after buying an additional 373 shares in the last quarter. Syon Capital LLC increased its position in shares of SPDR S&P Biotech ETF by 9.4% in the third quarter. Syon Capital LLC now owns 18,608 shares of the exchange traded fund’s stock valued at $1,865,000 after buying an additional 1,604 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of SPDR S&P Biotech ETF by 27.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after buying an additional 2,900,633 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its position in shares of SPDR S&P Biotech ETF by 60.9% in the 3rd quarter. PNC Financial Services Group Inc. now owns 70,527 shares of the exchange traded fund’s stock worth $7,067,000 after buying an additional 26,705 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 0.9%

Shares of NYSEARCA XBI opened at $126.74 on Friday. The company’s 50-day moving average price is $124.62 and its 200 day moving average price is $110.82. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $132.09. The stock has a market cap of $8.47 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.